Comments (0)
Share

Coronavirus: FDA authorizes VitalPatch for monitoring Covid-19 patients—Here's how it works

Publication/Creation Date
May 8 2020
Creators/Contributors
Tyler Mathisen (creator)
Vital Connect Inc. (creator)
Peter Van Haur (creator)
Food And Drug Administration (FDA) (contributor)
Media Type
News Broadcast
Persuasive Intent
Advertisement
Description
CNBC's Tyler Mathisen is joined by Vital Connect CEO Peter Van Haur to talk about how the company's VitalPatch product just got FDA approval to monitor coronavirus patients.
HCI Platform
Wearables
Discursive Type
Inventions
Location on Body
Chest
Augments
Treating, Communicating, Protecting, Monitoring
Technology Keywords
Biosensors, Remote Monitoring, Remote Patient Monitoring, Patch, Medical Device, Cloud Computing, Smartphones, Tablets
Keywords
COVID-19, Pandemic, Public Health, Health, Medical, Quarantine, Patients, Cardiovascular Health, Respiration, Vital Signs, United States
Marketing Keywords
Vital Connect, VitalPatch, Samsung, Amazon
Source
https://www.youtube.com/watch?v=gMe-wGhpyNg
Related Objects
Vital Connect - Vista Solution
Related Items
CNBC
Tyler Mathisen
Vital Connect Inc.
Peter Van Haur
Food And Drug Administration (FDA)
Related Collections
COVID-19 Tech (2020-2021)
Date archived
May 27 2020
Last edited
January 18 2021
How to cite this entry
Tyler Mathisen, Vital Connect Inc., Peter Van Haur. (May 8 2020). "Coronavirus: FDA authorizes VitalPatch for monitoring Covid-19 patients—Here's how it works". CNBC. Fabric of Digital Life. https://fabricofdigitallife.com/Detail/objects/4575